( Figure 4E,F).Therefore, we propose that TXNIP inhibits the activation of the MAPK signaling pathway bysuppressing the phosphorylation of the Erk1/2 protein in tumor cells, thereby inhibitingtumor cell proliferation. The gene discussed is MAPK3; the disease is neoplasm.